[Perspectives and plans to improve the prognosis of cervical cancer].
The cervical cancer has already attained high survival rate and there is a little room to improve the prognosis. The examination of recurred patients reveals that the recurrence was often found in the cervix, parametrium, pelvic wall, and distant organs. More intensive treatment to such part may be of beneficial to reduce recurrence. Post operative radiation to the pelvis for high risk patients seemed to improve the survival rate, although some authors failed to show its merit. Radiation to the para-aortic lymph node is matter of controversial. Chemotherapy is now expected to play an important role to control or prevent distant metastasis. Considering these facts, improvement of prognosis of the cervical cancer will be expected by 1. early detection by mass screening and 2. centralization the treatment facilities in order to do the individualized and multidisciplinary treatment.
Dept. of Gynecol. & Obstet., Saga Med. School.
H
H
Sugimori
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015182:Lymphatic Irradiation; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D017663:Peplomycin; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D014750:Vincristine / Q000008:administration & dosage
D008937:Mitomycins; D001761:Bleomycin; D016685:Mitomycin; D017663:Peplomycin; D014750:Vincristine; D002945:Cisplatin